LLY Articles, Eli Lilly and Company - From 07/10/24

An analysis of U.S. pharmacy claims data reveals that only one in four patients prescribed Novo Nordisk A/S’s (NYSE:NVO) weight-loss drugs, W...

Eli Lilly And Co (NYSE:LLY) agreed to acquire Morphic Holding Inc (NASDAQ:MORF) for $57 per share in cash, an aggregate of approximately $3....

The CNN Money Fear and Greed index showed a slight decline in the overall market sentiment, while the index remained in the “Neutral” z...

Eli Lilly and Co. (NYSE:LLY) has come out on top in a weight loss drug competition in a recent study. The study found that patients on Lilly’...

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite moving higher on Monday. The Dow traded down 0.12% to 39,329.47 while...

Monday, Eli Lilly And Co (NYSE:LLY) agreed to acquire Morphic Holding Inc (NASDAQ:MORF) for $57 per share in cash, an aggregate of approximate...

Eli Lilly and Co. (NYSE:LLY) shares are experiencing increased activity Friday afternoon. Here’s what you need to know. What’s Happenin...

In a study published in JAMA Network, patients with type 2 diabetes taking GLP-1 treatments have a reduced risk of developing ten types of obesity-...

Eli Lilly and Co (NYSE:LLY) has outperformed the market over the past 15 years by 11.54% on an annualized basis producing an average annual return ...

On Tuesday, the FDA approved Eli Lilly and Co’s (NYSE:LLY) Kisunla (donanemab) once-monthly injection for IV infusion) for adults with e...